• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.48 Up 0.00(0.52%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development5,969  5,340  7,711  
    Selling General and Administrative3,889  4,121  4,115  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (9,859) (9,460) (11,827)
    Income from Continuing Operations
    Total Other Income/Expenses Net544  660  (2,271)
    Earnings Before Interest And Taxes(9,315)(8,801)(14,098)
    Interest Expense63   -  397  
    Income Before Tax(9,378)(8,801)(14,495)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(9,378)(8,801)(14,495)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (9,378) (8,801) (14,495)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (9,378) (8,801) (14,495)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.